Latest Breaking News On - Evidence base for drug therapy - Page 1 : comparemela.com

Understudied but at risk, patients with preserved-EF heart failure but normal levels of the biomarker are in some ways intermediate between those with no HF and those with HFpEF and high NT-proBNP.

United statesFrederikh verbruggeGreggc fonarowUniversity of california los angeles medical centerBoehringer ingelheimEvidence base for drug therapyEuropean heart journalMayo clinicCalifornia los angeles medicalEvidence baseDrug therapyHeart failureB type natriuretic peptideHemodynamic monitoringEjection fraction efEft ventricular ejection fraction lvef